Zeng Hai, Zhou Jia, Huang Chenyang, Zhu Qingfeng
Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
J Stroke Cerebrovasc Dis. 2025 Jan;34(1):108137. doi: 10.1016/j.jstrokecerebrovasdis.2024.108137. Epub 2024 Nov 14.
This study aimed to assess whether the modified Pullicino formula could be used as a screening indicator for measuring infarct volume before endovascular thrombectomy (EVT) and observe baseline factors affecting neurological recovery in patients with acute anterior circulation large-core cerebral infarction.
The Pullicino formula × (1-22 %) was applied to anterior circulation large cerebral infarctions with ASPECTS <6 to screen patients with infarct volumes of 70-150 mL. The outcomes were assessed by mRS score at 90 days, modified Treatment in Cerebral Ischemia (mTICI) score, symptomatic intracranial hemorrhage within 48 h, and death rate within 90 days.
Significantly more patients in the EVT group with infarct volumes 70-150 mL had mRS ≤ 3 at 90 days than did the standard drug therapy (OR, 2.93; 95 % CI, 1.08-7.89, p = 0.03) and a significantly decreased mortality rate (OR, 0.36; 95 % CI, 0.13-0.98; p = 0.04), with 88.2 % in patients with mTICI ≥ 2b. There was no significant difference in the intracranial hemorrhage. EVT (adjusted OR [aOR], 2.84; 95 % CI, 1.15-7.01, p = 0.02), infarct volume <150 mL (aOR, 3.47; 95 % CI, 1.20-10.14, p = 0.02), and intracranial atherosclerosis (aOR, 4.20; 95 % CI, 1.24-14.04, p = 0.02) were significantly associated with patient prognosis.
Without commercial artificial intelligence software, the modified Pullicino formula can be used to calculate infarct volume and, in combination with ASPECTS <6, to select patients who may benefit from EVT.
本研究旨在评估改良的普利西诺公式是否可作为血管内血栓切除术(EVT)前测量梗死体积的筛查指标,并观察影响急性前循环大核心脑梗死患者神经功能恢复的基线因素。
将普利西诺公式×(1 - 22%)应用于ASPECTS<6的前循环大脑梗死,以筛选梗死体积为70 - 150 mL的患者。通过90天时的改良Rankin量表(mRS)评分、改良脑缺血治疗(mTICI)评分、48小时内症状性颅内出血和90天内死亡率评估结局。
与标准药物治疗相比,梗死体积为70 - 150 mL的EVT组患者90天时mRS≤3的比例显著更高(比值比[OR],2.93;95%置信区间[CI],1.08 - 7.89,p = 0.03),死亡率显著降低(OR,0.36;95% CI,0.13 - 0.98;p = 0.04),mTICI≥2b的患者比例为88.2%。颅内出血无显著差异。EVT(调整后OR[aOR],2.84;95% CI,1.15 - 7.01,p = 0.02)、梗死体积<150 mL(aOR,3.47;95% CI,1.20 - 10.14,p = 0.02)和颅内动脉粥样硬化(aOR,4.20;95% CI,1.24 - 14.04,p = 0.02)与患者预后显著相关。
在没有商业人工智能软件的情况下,改良的普利西诺公式可用于计算梗死体积,并结合ASPECTS<6,选择可能从EVT中获益的患者。